← Back to Search

Personalized Feedback Intervention for Anxiety and Hazardous Drinking

N/A
Recruiting
Led By Michael J Zvolensky, Ph.D.
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being between the age of 21 to 75 years of age
Being between the age of 21 to 75 years of age
Must not have
Current engagement in psychotherapy for anxiety
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline pre pfi completion to 6-months post pfi completion
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a computer-based intervention to reduce hazardous drinking among Latinx people with anxiety.

Who is the study for?
This trial is for Latinx individuals aged 21-75 who drink hazardously and have clinical anxiety. Participants must be fluent in Spanish, not currently pregnant, not undergoing psychotherapy for anxiety, and not involved in substance use programs.
What is being tested?
The study tests a computer-based intervention designed to educate about the risks of alcohol use with anxiety, motivate reduced drinking, and change attitudes towards using alcohol to cope with anxiety among Latinx drinkers.
What are the potential side effects?
Since this is a behavioral intervention involving personalized feedback rather than medication or medical procedures, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 75 years old.
Select...
I am between 21 and 75 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently in therapy for anxiety.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline pre pfi completion to 6-months post pfi completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline pre pfi completion to 6-months post pfi completion for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol Attitudes Scale
Modified Drinking Motives Questionnaire-Revised
Motivation to Reduce Alcohol Consumption Scale
Secondary study objectives
Alcohol Use Disorders Identification Test
Overall Anxiety Severity and Impairment Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Anxiety-alcohol personalized feedback intervention (AA-PFI 2.0)Experimental Treatment1 Intervention
Participants complete the brief (~20-30 minute) AA-PFI 2.0 at baseline.
Group II: Control personalized feedback intervention (C-PFI)Active Control1 Intervention
Participants complete the brief (~20-30 minute) C-PFI at baseline.

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
150 Previous Clinical Trials
47,669 Total Patients Enrolled
6 Trials studying Anxiety
1,166 Patients Enrolled for Anxiety
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
835 Previous Clinical Trials
1,082,624 Total Patients Enrolled
6 Trials studying Anxiety
3,177 Patients Enrolled for Anxiety
Michael J Zvolensky, Ph.D.Principal InvestigatorUniversity of Houston
5 Previous Clinical Trials
352 Total Patients Enrolled

Media Library

Alcohol-Anxiety Personalized Feedback Intervention 2.0 Clinical Trial Eligibility Overview. Trial Name: NCT05246202 — N/A
Anxiety Research Study Groups: Anxiety-alcohol personalized feedback intervention (AA-PFI 2.0), Control personalized feedback intervention (C-PFI)
Anxiety Clinical Trial 2023: Alcohol-Anxiety Personalized Feedback Intervention 2.0 Highlights & Side Effects. Trial Name: NCT05246202 — N/A
Alcohol-Anxiety Personalized Feedback Intervention 2.0 2023 Treatment Timeline for Medical Study. Trial Name: NCT05246202 — N/A
Anxiety Patient Testimony for trial: Trial Name: NCT05246202 — N/A
~100 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top